Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Medinotec (MDNC) Shares Outstanding (2022 - 2025)

Medinotec filings provide 4 years of Shares Outstanding readings, the most recent being $11.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed 0.19% to $11.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $11.8 million, a 0.19% change, with the full-year FY2025 number at $11.7 million, changed 0.0% from a year prior.
  • Shares Outstanding hit $11.8 million in Q4 2025 for Medinotec, roughly flat from $11.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $11.8 million in Q3 2025 to a low of $10.0 million in Q1 2022.
  • Median Shares Outstanding over the past 4 years was $11.7 million (2022), compared with a mean of $11.6 million.
  • The widest YoY moves for Shares Outstanding: up 17.34% in 2023, down 0.0% in 2023.
  • Medinotec's Shares Outstanding stood at $11.7 million in 2022, then changed by 0.0% to $11.7 million in 2023, then changed by 0.0% to $11.7 million in 2024, then rose by 0.19% to $11.8 million in 2025.
  • The last three reported values for Shares Outstanding were $11.8 million (Q4 2025), $11.8 million (Q3 2025), and $11.7 million (Q2 2025) per Business Quant data.